drugset / Trial / NCT01503801
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Phase 2/3
Completed
400 enrolled
Fudan University
Children's Hospital of Fudan University · collabChildren's Hospital of Hebei Province · collabHunan Children's Hospital · collabQuanZhou Women and Children's Hospital · collabShen-Zhen City Maternity and Child Healthcare Hospital · collabThe First Affiliated Hospital of Xiamen University · collabXiamen Women's and Children's Hospital · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Inhaled nitric oxide in preterm babies with respiratory failure or ventilator dependence will: 1. decrease the incidence of Bronchopulmonary Dysplasia (BPD) or death 2. shorten the length of oxygen therapy and hospital stay ,reduce the cost of hospital stay without increasing adverse effect
Timeline
- Start
- 2011-05
- Primary completion
- 2012-09
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 2 ppm | Inhaled |